
mTOR-Inhibitor-Attributed Events: Review of 2-Year Safety Data in Heart Transplant Recipients Receiving Everolimus Vs MMF in the Randomised Multi-Centre 2310 Study
Author(s) -
Mauro Rinaldi,
S. S. Wang,
Stephan Hirt,
Howard J. Eisen,
A. Keogh,
Massimo Boffini,
Christoph Bara,
Andreas Zuckermann,
Patricia López,
Michelle Cines,
H. Lehmkuhl
Publication year - 2012
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-201211271-00239
Subject(s) - everolimus , discovery and development of mtor inhibitors , medicine , heart transplantation , pi3k/akt/mtor pathway , sirolimus , transplantation , chemistry , apoptosis , biochemistry